Sep 7, 2018 FDA Approves Tiglutik, Liquid Form of Riluzole, for ALS Patients FDA Approves Tiglutik, Liquid Form of Riluzole, for ALS Patients... on riluzole (Rilutek) as the gold standard of treatment,” Hiroshi Mitsumoto, MD, a professor of neurology at Columbia University at The Neurological ... read morePublished on 2018-09-07